Type 1 Diabetes TrialNet
Study Participants Healthcare Professionals Researchers Locations Publications What is TrialNet? News and Events Get Screened! Home

Information for Study Participants

Long-Term Investigative Follow-Up in TrialNet (LIFT) Study

Status: Recruiting


Eligibility Criteria

NOTE: This study is open only to participants previously enrolled in a TrialNet Study

You can be screened for the LIFT Study, if:

  • You were previously enrolled in a TrialNet study for people newly diagnosed with type 1 diabetes,
  • You developed type 1 diabetes while participating in the Pathway to Prevention Study or a TrialNet prevention study.


About this Study

The LIFT Study is available nationwide to TrialNet participants who either:

  • developed diabetes while being monitored in the Pathway to Prevention Study or during participation in any prevention trial. The purpose is to study people early in the disease process. If you were diagnosed while taking part in a TrialNet study, you offer a unique opportunity for scientists to learn more about the disease in its earliest stages;


  • participated in  any new onset studies.  The purpose is to learn more about diabetes and if there are any long-term effects—good or bad—from the treatments used in these studies


What will I be asked to do?

Participants will be asked to return to a TrialNet site annually or semi- annually, based on their ongoing ability to produce insulin. Visits will include metabolic testing (i.e., Oral Glucose Tolerance Test and/or Mixed Meal Tolerance Test), HbAc1, and possibly other blood or urine tests.


To learn if you might be eligible for this study, contact a staff member at the site where you took part in a TrialNet study.

Information will be kept confidential.

Back To Top